In Mr. McDermott’s 21 years as a consultant, he has focused on value proposition development, burden of illness and health economic studies, Medicare and managed-care payment strategies, new product launch planning, and payer and provider market research for cardiology, gastroenterology, hematology, neurology, oncology and urology drugs and devices.